ID FL-18 AC CVCL_8093 SY FL18 DR BTO; BTO_0002518 DR cancercelllines; CVCL_8093 DR Cosmic; 2396144 DR GEO; GSM3150244 DR IARC_TP53; 5999 DR PRIDE; PXD012087 DR Wikidata; Q54834952 RX DOI=10.1016/B978-0-12-221970-2.50457-5; RX PubMed=1967982; RX PubMed=2822175; RX PubMed=3034807; RX PubMed=3928551; RX PubMed=8847894; RX PubMed=8878455; RX PubMed=12967475; RX PubMed=14990977; RX PubMed=15028022; RX PubMed=26727417; CC Population: Japanese. CC Doubling time: 36-48 hours (PubMed=3928551); 25.3 hours (PubMed=8847894). CC Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=12967475). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser127Phe (c.380C>T); ClinVar=VCV000182928; Zygosity=Unspecified (PubMed=8878455). CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Misspelling: AKA96-3; IARC_TP53=5999; Note=Not really a misspelling but an assignment of a name based on first author of publication and date because assignment of correct cell line name was not done correctly. CC Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. DI NCIt; C3209; Follicular lymphoma DI ORDO; Orphanet_545; Follicular lymphoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) OI CVCL_J353 ! FL-18-EB SX Male AG 68Y CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 26 // RX PubMed=3928551; DOI=10.20772/cancersci1985.76.7_563; RA Ohno, Hitoshi RA Doi, Shoichi RA Fukuhara, Shiro RA Nishikori, Masaru RA Uchino, Haruto RA Fujii, Hiroshi RT "A newly established human lymphoma cell line, FL-18, carrying a 14;18 RT translocation."; RL Jpn. J. Cancer Res. 76:563-566(1985). // RX PubMed=15028022; DOI=10.1111/j.1440-1827.2004.01612.x; RA Kamimura, Katsuhito RA Hojo, Hiroshi RA Abe, Masafumi RT "Characterization of expression of protein kinase C isozymes in human RT B-cell lymphoma: relationship between its expression and prognosis."; RL Pathol. Int. 54:224-230(2004). // RX DOI=10.1016/B978-0-12-221970-2.50457-5; RA Drexler, Hans Gunther RT "The leukemia-lymphoma cell line factsbook."; RL (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001). // RX PubMed=14990977; DOI=10.1038/sj.leu.2403323; RA Hardianti, Mardiah Suci RA Tatsumi, Eiji RA Syampurnawati, Meilani RA Furuta, Kiyoshi RA Saigo, Katsuyasu RA Nakamachi, Yuji RA Kumagai, Shunichi RA Ohno, Hitoshi RA Tanabe, Satoru RA Uchida, M. RA Yasuda, Norimasa RT "Activation-induced cytidine deaminase expression in follicular RT lymphoma: association between AID expression and ongoing mutation in RT FL."; RL Leukemia 18:826-831(2004). // RX PubMed=8847894; RA Tani, Akiyoshi RA Tatsumi, Eiji RA Nakamura, Fumihiko RA Kumagai, Shunichi RA Kosaka, Yoshiyuki RA Sano, Kimihiko RA Nakamura, Hajime RA Amakawa, Ryuichi RA Ohno, Hitoshi RT "Sensitivity to dexamethasone and absence of bcl-2 protein in RT Burkitt's lymphoma cell line (Black93) derived from a patient with RT acute tumor lysis syndrome: comparative study with other BL and non-BL RT lines."; RL Leukemia 10:1592-1603(1996). // RX PubMed=26727417; DOI=10.3109/10428194.2015.1108414; RA Drexler, Hans Gunther RA Eberth, Sonja RA Nagel, Stefan RA MacLeod, Roderick A.F. RT "Malignant hematopoietic cell lines: in vitro models for double-hit RT B-cell lymphomas."; RL Leuk. Lymphoma 57:1015-1020(2016). // RX PubMed=1967982; DOI=10.1016/0092-8674(90)90657-Z; RA Nourse, Jamisqn RA Mellentin, Julia D. RA Galili, Naomi RA Wilkinson, Joyce RA Stanbridge, Eric John RA Smith, Stephen D. RA Cleary, Michael L. RT "Chromosomal translocation t(1;19) results in synthesis of a homeobox RT fusion mRNA that codes for a potential chimeric transcription RT factor."; RL Cell 60:535-545(1990). // RX PubMed=3034807; DOI=10.1002/ijc.2910390622; RA Ohno, Hitoshi RA Fukuhara, Shiro RA Takahashi, Rei RA Mihara, Koh-ichirou RA Sugiyama, Taketoshi RA Doi, Shoichi RA Uchino, Haruto RA Toyoshima, Kumao RT "c-yes and bcl-2 genes located on 18q21.3 in a follicular lymphoma RT cell line carrying a t(14;18) chromosomal translocation."; RL Int. J. Cancer 39:785-788(1987). // RX PubMed=2822175; DOI=10.1182/blood.V70.5.1619.1619; RA Doi, Shoichi RA Ohno, Hitoshi RA Tatsumi, Eiji RA Arita, Yuu RA Kamesaki, Hiroshi RA Fukuhara, Shiro RA Nishikori, Masaru RA Miwa, Hiroshi RA Kita, Kenkichi RA Hatanaka, Masakazu RA Honjo, Tasuku RA Fujii, Hiroshi RA Uchino, Haruto RT "Lymphoma cell line (FL-18) and Epstein-Barr virus-carrying cell line RT (FL-18-EB) obtained from a patient with follicular lymphoma: RT monoclonal derivation and different properties."; RL Blood 70:1619-1623(1987). // RX PubMed=8878455; DOI=10.1111/j.1349-7006.1996.tb02122.x; PMCID=PMC5921203; RA Akasaka, Takashi RA Muramatsu, Mikiko RA Kadowaki, Norimitsu RA Ohno, Hitoshi RA Ishizaki, Kanji RA Yamabe, Hirohiko RA Fukuhara, Shiro RA Okuma, Minoru RT "p53 mutation in B-cell lymphoid neoplasms with reference to oncogene RT rearrangements associated with chromosomal translocations."; RL Jpn. J. Cancer Res. 87:930-937(1996). // RX PubMed=12967475; DOI=10.1111/j.1349-7006.2003.tb01518.x; PMCID=PMC11160262; RA Maesako, Yoshitomo RA Uchiyama, Takashi RA Ohno, Hitoshi RT "Comparison of gene expression profiles of lymphoma cell lines from RT transformed follicular lymphoma, Burkitt's lymphoma and de novo RT diffuse large B-cell lymphoma."; RL Cancer Sci. 94:774-781(2003). //